Synthesis of Novel Heterocyclic Compounds for Antitumor and Radioprotective Activities
摘要:
Some novel pyridothienoxazine (5); pyridothienopyrmidines (6), (8), (9), (14); pyridothienoimidazole (16); isothiazolopyridine (17), and pyridoisothiazolopyrimidines (18-20) were synthesized. The structural assignment of the prepared compounds were based on microanalytical and spectroscopic evidences. Some prepared compounds were tested in vitro for their antitumor and radioprotective activities. Compounds (7), (12), (17) and (19) showed significant activities against EAC cells, at a concentration of 250 mug/ml; while the isothiazolopyridine (17) exhibited radioprotective activity.
Synthesis of Novel Heterocyclic Compounds for Antitumor and Radioprotective Activities
摘要:
Some novel pyridothienoxazine (5); pyridothienopyrmidines (6), (8), (9), (14); pyridothienoimidazole (16); isothiazolopyridine (17), and pyridoisothiazolopyrimidines (18-20) were synthesized. The structural assignment of the prepared compounds were based on microanalytical and spectroscopic evidences. Some prepared compounds were tested in vitro for their antitumor and radioprotective activities. Compounds (7), (12), (17) and (19) showed significant activities against EAC cells, at a concentration of 250 mug/ml; while the isothiazolopyridine (17) exhibited radioprotective activity.
Synthesis of Novel Heterocyclic Compounds for Antitumor and Radioprotective Activities
作者:M.-M. Ghorab、A.-Y. Hassan、O.-M. Nassar
DOI:10.1080/10426509808545486
日期:1998.2.1
Some novel pyridothienoxazine (5); pyridothienopyrmidines (6), (8), (9), (14); pyridothienoimidazole (16); isothiazolopyridine (17), and pyridoisothiazolopyrimidines (18-20) were synthesized. The structural assignment of the prepared compounds were based on microanalytical and spectroscopic evidences. Some prepared compounds were tested in vitro for their antitumor and radioprotective activities. Compounds (7), (12), (17) and (19) showed significant activities against EAC cells, at a concentration of 250 mug/ml; while the isothiazolopyridine (17) exhibited radioprotective activity.